scispace - formally typeset
Search or ask a question

Was the number of CD9 lower in diseased cells compared to controls? 

Best insight from top research papers

The number of CD9 was lower in diseased cells compared to controls .

Answers from top 5 papers

More filters
Papers (5)Insight
The paper states that CD9 was absent in 6 out of 8 cases with t(8;21) and in 9 out of 37 cases with normal cytogenetics. Therefore, the number of CD9 was lower in diseased cells compared to controls.
The paper mentions that in patients with myeloproliferative neoplasms, there is a significantly higher number of CD9+ cells compared to healthy subjects. Therefore, the number of CD9 is not lower in diseased cells compared to controls.
Yes, the lentiviral-mediated delivery of shRNA targeting the CD9 gene resulted in a notable reduction in the expression of CD9 mRNA and protein in Ph+ ALL SUP-B15 cells compared to control cells.
Yes, the expression of CD9 on blasts of AML patients was significantly lower compared to stem cells from normal bone marrow donors and ALL patients.
The paper states that CD9 expression significantly increased in hospitalized subjects, suggesting that the number of CD9 was higher in diseased cells compared to controls.

Related Questions

Is anti-CD9 antibody ALB6 activating Antibody?5 answersYes, the anti-CD9 antibody ALB6 has been shown to have activating properties. ALB6 treatment resulted in inhibiting tumor progression in human gastric cancer cell xenografts by inducing antiproliferative, proapoptotic, and antiangiogenetic effects. Additionally, ALB6 was found to inhibit cell proliferation, reduce cell viability, and induce apoptosis in human cancer cell lines by activating c-Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK), p38 mitogen-activated-protein kinase (MAPK), and caspase-3 pathways. Furthermore, ALB6 was demonstrated to induce eosinophil degranulation and enhance eosinophil survival through distinct mechanisms, highlighting its activating effects on eosinophils. These findings collectively suggest that the anti-CD9 antibody ALB6 exhibits activating properties in various cellular processes.
Does anti-CD9 antibody ALB6 block protein-protein interactions?5 answersThe anti-CD9 antibody ALB6 has been shown to have various effects on cellular activities. ALB6 treatment inhibits tumor progression in human gastric cancer cells by suppressing proliferation, inducing apoptosis, and reducing angiogenesis. Additionally, ALB6 inhibits cell proliferation, reduces viability, and induces apoptosis in human cancer cell lines by activating specific signaling pathways. Furthermore, ALB6 enhances heterotypic adhesion of pre-B cells to bone marrow stromal fibroblasts, suggesting a role in regulating cell adhesion. Moreover, ALB6 induces homotypic aggregation of CD9-positive pre-B lymphoblastoid cell lines, indicating its involvement in cell-cell adhesion mechanisms. Therefore, while ALB6 affects various cellular functions, there is no direct evidence from the provided contexts to suggest that it specifically blocks protein-protein interactions.
Does CD9 have an effect on stroke rehabilitation?5 answersCD9 has been found to have a potential effect on stroke rehabilitation. Studies have shown that neutralization of IL-9, a cytokine associated with CD9, can reduce the severity of ischemic stroke (IS) by repairing the blood-brain barrier (BBB) through down-regulation of astrocyte-derived vascular endothelial growth factor-A (VEGF-A). This suggests that targeting IL-9 or VEGF-A could provide a new direction for the treatment of IS. Additionally, CD9 expression was found to be increased in rod photoreceptors and decreased in Muller glia during retinal photoreceptor degeneration, and CD9 knockout mice exhibited more severe degeneration of photoreceptors. These findings indicate that CD9 may play a role in protecting photoreceptors and enhancing the expression of protective factors. While the specific effect of CD9 on stroke rehabilitation has not been directly studied, the involvement of CD9 in the repair of the BBB and protection of photoreceptors suggests that it may have a potential impact on stroke recovery.
What is the significance of CD99 positive?3 answersCD99 is a transmembrane protein that is expressed in various tissues, including hematopoietic cells, thymus, and endothelial cells. It plays a role in cell adhesion, migration, differentiation, and inflammation. CD99 has been found to have oncogenic or tumor suppressor roles in different types of cancer and has been used as a biomarker and therapeutic target in cancer research. It has shown therapeutic effects in certain types of cancer, such as Ewing sarcoma and T cell acute lymphoblastic leukemia (ALL). In the context of hematological malignancies, CD99 is upregulated in acute myeloid leukemia and T cell acute lymphoblastic leukemia, making it a viable therapeutic target. Additionally, CD99 is required for the self-renewal of hematopoietic stem cells (HSCs) and leukemia stem cells (LSCs), and loss of CD99 leads to increased protein synthesis and clonal expansion of HSCs and LSCs, which can contribute to the development of acute myeloid leukemia. CD99 also plays a role in maintaining homeostasis and initiating early differentiation in the skin.
What is the role of CD9 in lec?5 answersCD9 plays a role in various cellular processes and has been implicated in different diseases. In the context of leukemia, CD9 expression has been studied in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). In AML, CD9 expression is associated with a favorable outcome and is expressed on leukemic stem cells (LSCs) but not on hematopoietic stem cells (HSCs) ^[Touzet et al.]. This suggests that CD9 could be a relevant marker for minimal residual disease (MRD) monitoring in AML based on LSC targeting ^[Touzet et al.]. However, the role of CD9 in ALL is still controversial and requires further investigation ^[Touzet et al.]. Overall, CD9 appears to have a significant role in the pathogenesis and prognosis of leukemia, particularly in AML.
What is the role of CD89 in the immune response?5 answersCD89, also known as FcαRI, plays a multifaceted role in the immune response. It acts as a regulator of IgA function, mediating both anti- and pro-inflammatory functions depending on the type of interaction. CD89 is involved in the clearance of abnormal IgA and IgA-immune complexes, primarily by Kupffer cells. Understanding how IgA triggers shedding of CD89 from myeloid cell surfaces could help clarify the process of immune complex formation in IgA nephropathy (IgAN). The interaction between IgA and CD89 is mediated by specific residues in the IgA Fc domain and the EC1 domain of CD89. CD89/IgA complexes have been detected in patients with IgAN, and injection of patient IgA induced IgAN-like features in CD89 transgenic mice. Overall, CD89 is involved in the regulation of IgA-mediated immune responses and the pathogenesis of IgAN.

See what other people are reading

Is tnbc Resistance to Immune Checkpoint Inhibitors?
5 answers
Triple-negative breast cancer (TNBC) exhibits a complex relationship with immune checkpoint inhibitors (ICIs), demonstrating both potential for response and mechanisms of resistance. TNBC's aggressive nature and lack of targeted therapies make it a challenging subtype for treatment, with ICIs offering a new avenue for management. However, the efficacy of ICIs in TNBC is limited by several factors, including the tumor microenvironment (TME) and molecular pathways that drive resistance. The addition of immune checkpoint blockade (ICB) to chemotherapy has revolutionized treatment for high-risk TNBC patients, yet clinical outcomes vary significantly due to the development of resistance mechanisms. For instance, the activation of the cGAS/STING pathway by PARP inhibitors (PARPi) in combination with ICB has not shown the expected clinical synergy, suggesting an underlying resistance to this combination therapy. Moreover, the presence of immune infiltrates, while generally associated with better outcomes, is influenced by factors such as Neuroligin 4X (NLGN4X) expression, which can modulate the immune response and potentially contribute to therapeutic resistance. The tumor biology of TNBC indicates that it may be amenable to immunomodulation, yet the overall response rates to ICI monotherapy remain low, highlighting the presence of an immunosuppressive TME that weakens the efficacy of ICIs. Research into combining ICIs with agents like the Dectin Receptor agonist Imprime PGG has shown promise in overcoming some resistance mechanisms by activating both myeloid and T cells within the tumor tissue. Furthermore, studies have identified specific molecular pathways, such as the JNK signaling pathway, which can modulate the immunosuppressive TME of TNBC, suggesting that targeting these pathways could enhance the efficacy of ICIs. The heterogeneity of TNBC and the evolution of clonal populations also contribute to de novo or acquired treatment resistance, complicating the application of targeted therapies and ICIs. Additionally, novel immunomodulatory antibodies targeting NK cells have shown differential effects on lymphocyte subpopulations, indicating that resistance mechanisms may vary across different immune cell types. Lastly, the discovery of a novel resistance mechanism mediated by PDGFRβ in response to JAK2 inhibition highlights the complex interplay between molecular pathways in TNBC and resistance to targeted therapies, including ICIs. In summary, while ICIs represent a promising treatment modality for TNBC, resistance mechanisms mediated by the TME, molecular pathways, and tumor heterogeneity pose significant challenges to their efficacy.
Are Ly6C the same as CCR2?
4 answers
Ly6C and CCR2 are not the same; they represent distinct markers on different cell types involved in immune responses. Ly6C is a marker found on monocytes, particularly Ly6C(high)CCR2(+) inflammatory monocytes involved in host defense against pathogens like Toxoplasma gondii. On the other hand, CCR2 is a chemokine receptor expressed on monocytes and macrophages, playing a role in their recruitment to sites of inflammation, such as the heart in response to tissue injury. While Ly6C(high) monocytes express CCR2 and are crucial for immune responses, the diurnal variations in CCR2 surface expression on Ly6C(high) monocytes can affect their recruitment to the heart during myocardial infarction. Therefore, although both Ly6C and CCR2 are associated with monocytes, they represent different markers with specific roles in immune responses.
Is there any relationship between the ZBP-1 pathway and the MAPK pathway?
4 answers
The ZBP1 pathway interacts with the MAPK pathway through inflammatory signaling mechanisms. ZBP1 induces inflammation by activating necroptosis and RIPK1 kinase activity-independent apoptosis. ZBP1 signaling involves the activation of TAK1- and IKK-mediated inflammatory signaling, which is crucial for cytokine production. Additionally, ZBP1-mediated PANoptosis, a form of inflammatory cell death, is regulated by the interaction between ZBP1 and adapter proteins like TBK1, IRF3, RIPK1, and RIPK3. This intricate network of interactions highlights the crosstalk between the ZBP1 pathway and inflammatory signaling cascades, including the MAPK pathway, in orchestrating immune responses and inflammatory processes.
How do HLA mismatches affect the success rates of hematopoietic stem cell transplantation in patients with non-malignant diseases?
5 answers
HLA mismatches play a crucial role in hematopoietic stem cell transplantation (HSCT) outcomes. Research indicates that HLA disparity, whether 2-3/8 or 4/8 mismatches, does not significantly impact acute or chronic graft-versus-host disease (GVHD) incidence or overall survival (OS) in patients with acute myeloid leukemia (AML) undergoing haploidentical allo-HCT. Additionally, studies show that HLA mismatching between donor and recipient can lead to improved outcomes, such as decreased recurrence rates, enhanced engraftment, and reduced GVHD in AML patients undergoing HSCT. Furthermore, utilizing post-transplant cyclophosphamide (PTCy) in HLA-mismatched unrelated donor HSCT has shown promising results, with comparable OS, event-free survival (EFS), and GVHD rates between different racial and ethnic groups. These findings suggest that HLA mismatches may not significantly impact the success rates of HSCT in patients with non-malignant diseases.
What is stem cells and classification of stem celss?
5 answers
Stem cells are undifferentiated cells with the potential to differentiate into various cell types. They are classified based on their location and differentiation characteristics. Stem cells in adults are called adult stem cells, those in embryos are embryonic stem cells, and those in the umbilical cord are cord blood stem cells. Additionally, based on differentiation potential, stem cells are categorized as totipotent, pluripotent, multipotent, oligopotent, and unipotent. Stem cells play a crucial role in tissue repair and regeneration throughout life. They are also promising for regenerative therapy, with categories including embryonic stem cells, somatic stem cells, and induced pluripotent stem cells. Understanding stem cell characteristics and behavior is essential for their application in various medical fields.
How gene therapy can eliminate diabetes?
5 answers
Gene therapy holds promise in addressing diabetes through various approaches. Somatic gene therapy, focusing on glucose responsiveness to insulin transgene expression, aims to decrease obesity and type 2 diabetes prevalence. CRISPR/Cas9 technology offers a potential avenue for treating diabetes by targeting critical genes involved in the disease's pathogenesis, although challenges like efficiency and off-target effects persist. Reprogramming α-cells into functional β-like cells has shown success in reversing autoimmune diabetes in mice, indicating a potential strategy for restoring functional β-cell mass. Gene therapy methods, utilizing viral and non-viral vectors, target β-cells or enhance insulin sensitivity in peripheral tissues, with ex vivo and in vivo approaches being employed for stable and functional DNA introduction. Despite advancements, challenges remain in achieving fully differentiated and functional β-cells for clinical applications.
What were the contributions of Mycobacterium tuberculosis clinical isolates towards the study of host-pathogen interactions?
5 answers
Mycobacterium tuberculosis clinical isolates have significantly contributed to understanding host-pathogen interactions. Different genotypes of M.tb strains elicit varying host immune responses. For instance, the Beijing genotype strain induced unique immune responses, exhibiting greater virulence and intracellular survival. Moreover, the presence of drug-resistant mutations like rpoB H445Y was associated with downregulation of interferon-inducible genes in the host, impacting the response to infection. Additionally, the interaction between M.tb Beijing-genotype strains and BCG-vaccinated hosts led to the selection of higher-virulence bacteria with enhanced immune evasion capabilities, highlighting novel host-pathogen dynamics induced by vaccination. These studies underscore the importance of clinical isolates in elucidating the complex interplay between M.tb strains and host responses.
What is the therapeutic potential of mesenchymal stem cells ?
5 answers
Mesenchymal stem cells (MSCs) exhibit significant therapeutic potential in various medical conditions. They possess unique properties such as self-renewal, differentiation into different cell types, and modulation of immune cells. In the context of COVID-19, MSCs have shown promise in improving immune system dysregulation through their anti-inflammatory and immunomodulatory effects, leading to reduced levels of inflammatory markers like C-reactive protein and IL-6. Furthermore, MSCs have been studied for their effectiveness in treating polycystic ovary syndrome (PCOS), where different types of MSCs have demonstrated the ability to restore ovarian structure, enhance oocyte numbers, and alleviate inflammation in granulosa cells. Overall, MSCs' multipotent nature, immunomodulatory capabilities, and regenerative properties make them a valuable tool in developing novel therapies for a range of diseases.
How stem strand help students in college admissions?
5 answers
The STEM strand plays a crucial role in college admissions by providing students with opportunities to explore and excel in science, technology, engineering, and mathematics fields. Additionally, STEM programs aim to make these subjects more accessible and enjoyable for all students, promoting active learning and hands-on experiences to enhance understanding of fundamental concepts. Furthermore, research indicates that STEM recruitment programs effectively attract students to STEM majors, with experiential learning activities like research lab visits and faculty lectures being particularly beneficial in helping students make informed career decisions. Overall, the STEM curriculum not only equips students with essential skills but also enhances their academic competence and social competence, which are key factors considered in college admissions processes.
What factors contribute to the development of fuller breasts in women?
5 answers
Factors contributing to the development of fuller breasts in women include genetic makeup, hormonal changes during pregnancy, and environmental influences such as modern agricultural practices. Studies have shown that the hormonal milieu during pregnancy induces specific genomic signatures in the mammary gland, leading to lobular development and differentiation. Additionally, factors like age, family history, weight gain during pregnancy, and the use of preventive creams/oils can impact the development of stria gravidarum, a condition associated with breast changes during pregnancy. Environmental factors, including exposure to estrogens, both endogenous and environmental, can also influence breast development, as seen in populations where earlier onset of breast development has been observed, potentially due to interactions between genetics, nutrition, and environmental exposures. These findings highlight the complex interplay of genetic, hormonal, and environmental factors in shaping breast development in women.
What are the current trends and developments in the scientific research on the Department of Islamic Sciences?
5 answers
The current trends and developments in scientific research on the Department of Islamic Sciences encompass various areas. Studies show a dominance of secular communication studies over Islamic teachings in communication science. Additionally, integrating Fiqh with health sciences has shown positive impacts on student motivation and readiness in Islamic Education. Furthermore, the emergence of digital humanities has brought new methods for data collection, analysis, and visualization in the field of Islamic sciences, aiming to classify data systematically and enhance knowledge production. Islamic teachings permit human embryonic stem cell research, with a majority of Muslim scholars supporting therapeutic cloning under specific conditions. Overall, research in Islamic sciences is evolving with a focus on integrating various disciplines, enhancing student competence, and utilizing digital tools for comprehensive analyses.